Our journey began with a deep fascination for the intricate world of the human gut bacterial ecosystem and its profound impact on overall well-being.  Our founders, a team of passionate researchers and healthcare professionals, were intrigued by the pivotal role this complex microbiota plays in maintaining human health.  The various bacteria produce a complex, yet synergistic, set of metabolites in our intestines that exhibit profound, wide-ranging effects on metabolism and immune function.

​​

​​

​​

​As we delved deeper into the science, we uncovered the potential of these biosynthetic molecules, that mimic naturally occurring substances, in addressing a variety of health challenges, from autoimmune disease to metabolic disorders. We were particularly captivated by how these simple organic compounds could influence complex cellular processes and serve as a communication bridge between our gut microbiome and immune system.

​

​​

​​​​​

We discovered ways to manipulate the molecular structure and develop oral delivery formulations, increasing the selectivity and specificity of our biosynthetic compounds after elucidating pathways and targets.  We have developed a platform technology that allows us to target specific diseases and create disease-specific drugs.  ​​​​Our technology platform represents a convergence of microbial science, pharmaceutical innovation, and precision medicine, offering new hope for patients across multiple therapeutic areas.  

​

​Join us on this exciting journey as we work towards a healthier future, one molecule at a time.